After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...
The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...
Most compounded versions of popular ... thereby causing weight loss. Some people are overdosing on semaglutide, FDA warns Ozempic is approved by the FDA to treat Type 2 diabetes, but some doctors ...
The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...